{
    "root": "aae490e3-adff-41cc-ad39-488f5449f7b6",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Divalproex Sodium",
    "value": "20250228",
    "ingredients": [
        {
            "name": "DIVALPROEX SODIUM",
            "code": "644VL95AO6"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "2165RE0K14"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER",
            "code": "NX76LV5T8J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25219"
        },
        {
            "name": "DIETHYL PHTHALATE",
            "code": "UF064M00AF",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_34698"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SOYBEAN LECITHIN",
            "code": "1DI56QDM62",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_61995"
        },
        {
            "name": "VANILLIN",
            "code": "CHI530446X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_18346"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        }
    ],
    "indications": {
        "text": "divalproex sodium anti-epileptic indicated : \u2022 treatment manic episodes associated bipolar disorder ( 1.1 ) \u2022 monotherapy adjunctive therapy complex partial seizures simple complex absence seizures ; adjunctive therapy patients multiple seizure types include absence seizures ( 1.2 ) \u2022 prophylaxis migraine headaches ( 1.3 )",
        "doid_entities": [
            {
                "text": "bipolar disorder (DOID:3312)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3312"
            },
            {
                "text": "migraine (DOID:6364)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6364"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "divalproex sodium delayed-release tablets intended oral . divalproex sodium delayed-release tablets swallowed whole crushed chewed . patients informed take divalproex sodium delayed-release tablets every day prescribed . dose missed taken soon possible , unless almost time next dose . dose skipped , patient double next dose .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "divalproex sodium delayed-release tablets , usp supplied : divalproex sodium delayed-release tablets usp , 250 mg peach colored , oval shaped enteric-coated tablets , imprinted \u201c 85 \u201d one side black edible ink plain side . overbagged 10 tablets per bag , ndc 55154-7145-0 divalproex sodium delayed-release tablets usp , 500 mg pink colored , oval shaped enteric-coated tablets , imprinted \u201c 86 \u201d one side black edible ink plain side . overbagged 10 tablets per bag , ndc 55154-4679-0 recommended storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . protection : blister torn broken .",
    "adverseReactions": "\u2022divalproex sodium delayed-release tablets administered patients hepatic disease significant hepatic dysfunction [ ( 5.1 ) ] . \u2022divalproex sodium delayed-release tablets contraindicated patients known mitochondrial disorders caused mutations mitochondrial dna polymerase \u03b3 ( polg ; e.g . , alpers-huttenlocher syndrome ) children two years age suspected polg-related disorder [ ( 5.1 ) ] . \u2022divalproex sodium delayed-release tablets contraindicated patients known hypersensitivity [ ( 5.12 ) ] . \u2022divalproex sodium delayed-release tablets contraindicated patients known urea cycle disorders [ ( 5.6 ) ] . \u2022for prophylaxis migraine headaches : divalproex sodium delayed-release tablets contraindicated women pregnant women childbearing potential using effective contraception [ ( 5.2 , 5.3 , 5.4 ) ( 8.1 ) ] .",
    "indications_original": "Divalproex sodium is an anti-epileptic drug indicated for: \u2022 Treatment of manic episodes associated with bipolar disorder ( 1.1 ) \u2022 Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1.2 ) \u2022 Prophylaxis of migraine headaches ( 1.3 )",
    "contraindications_original": "Divalproex sodium delayed-release tablets are intended for oral administration. Divalproex sodium delayed-release tablets should be swallowed whole and should not be crushed or chewed.\n                  Patients should be informed to take divalproex sodium delayed-release tablets every day as prescribed. If a dose is missed it should be taken as soon as possible, unless it is almost time for the next dose. If a dose is skipped, the patient should not double the next dose.",
    "warningsAndPrecautions_original": "Divalproex sodium delayed-release tablets, USP are supplied as:\n                  \n                     Divalproex Sodium Delayed-Release Tablets USP, 250 mg are peach colored, oval shaped enteric-coated tablets, imprinted with \u201cD 85\u201d on one side with black edible ink and plain on other side.   \n                  Overbagged with 10 tablets per bag, NDC 55154-7145-0\n                  \n                     Divalproex Sodium Delayed-Release Tablets USP, 500 mg are pink colored, oval shaped enteric-coated tablets, imprinted with \u201cD 86\u201d on one side with black edible ink and plain on other side.   \n                  Overbagged with 10 tablets per bag, NDC 55154-4679-0\n                  Recommended Storage   \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].  \n                  \n                     FOR YOUR PROTECTION: Do not use if blister is torn or broken.",
    "adverseReactions_original": "\u2022Divalproex sodium delayed-release tablets should not be administered to patients with hepatic disease or significant hepatic dysfunction     [see      Warnings and Precautions (5.1)].     \n                     \n                     \n                        \u2022Divalproex sodium delayed-release tablets are contraindicated in patients known to have mitochondrial disorders caused by mutations in mitochondrial DNA polymerase \u03b3 (POLG; e.g., Alpers-Huttenlocher Syndrome) and children under two years of age who are suspected of having a POLG-related disorder     [see      Warnings and Precautions (5.1)].     \n                     \n                     \n                        \u2022Divalproex sodium delayed-release tablets are contraindicated in patients with known hypersensitivity to the drug     [see      Warnings and Precautions (5.12)].     \n                     \n                     \n                        \u2022Divalproex sodium delayed-release tablets are contraindicated in patients with known urea cycle disorders     [see      Warnings and Precautions (5.6)].     \n                     \n                     \n                        \u2022For use in prophylaxis of migraine headaches: Divalproex sodium delayed-release tablets are contraindicated in women who are pregnant and in women of childbearing potential who are not using effective contraception     [see      Warnings and Precautions (5.2,      5.3,      5.4) and      Use in Specific Populations (8.1)].",
    "drug": [
        {
            "name": "Divalproex Sodium"
        }
    ]
}